Therapy Related Acute Promyelocytic Leukaemia (APML) in a Breast Cancer Survivor: Another Tale of an Ally Turned AdversaryCorrespondence Address :
Dr. Sujaya Mazumder,
C12, Sreenivasa Towers, Oulgaret, Puducherry-506010, India.
With an increase in the use of high dose chemotherapeutic regimens, higher cure rates and longer survival periods of cancer patients, the incidence of secondary malignancies are increasing. Therapy related Myeloid Neoplasm (t-MN) is a second malignancy after chemotherapy/radiotherapy given for a prior malignancy. Of the various t-MN Acute Promyelocytic Leukaemia (APML) as a complication of chemo-radiotherapy is very rare. We report a rare case of therapy related APML in a breast cancer survivor.
Secondary, Topoisomerase II inhibitor, Therapy related myeloid neoplasm
Sujaya Mazumder, Debdatta Basu, Biswajit Dubashi. THERAPY RELATED ACUTE PROMYELOCYTIC LEUKAEMIA (APML) IN A BREAST CANCER SURVIVOR: ANOTHER TALE OF AN ALLY TURNED ADVERSARY. Journal of Clinical and Diagnostic Research [serial online] 2019 March [cited: 2019 Feb 18 ]; 13:ED03-ED04. Available from
Date of Submission: Dec 17, 2018
Date of Peer Review: Jan 09, 2019
Date of Acceptance: Jan 17, 2019
Date of Publishing: Mar 01, 2019
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)